Written by Klarity Editorial Team
Published: Jul 16, 2026

Last updated: July 16, 2026
2026 CVS Caremark Formulary Update: HMSA members on CVS Caremark may access SSRIs and SNRIs at Tier 1–2 with no prior authorization in most plans. Benzodiazepines typically fall at Tier 2 with quantity limits but do not require electronic prescribing under Hawaii law (HRS § 329-38.5 covers Schedule II only — anxiety medications are not subject to Hawaii’s EPCS mandate). Ready to explore anxiety treatment? See if you may qualify at Klarity Health →
If you have Hawaii Medical Service Association (HMSA) health insurance and you or a loved one is managing anxiety, understanding your coverage can feel just as stressful as the condition itself. HMSA — Hawaii’s Blue Cross Blue Shield plan and the state’s largest insurer — works with CVS Caremark as its pharmacy benefits manager (PBM) to administer prescription drug coverage for most commercial and employer-sponsored plans.
This 2026 guide walks through what HMSA may cover for anxiety treatment, how CVS Caremark’s formulary typically tiers anxiety medications, what Hawaii’s mental health parity law (Haw. Rev. Stat. § 431M-1) requires, and how the Hawaii Prepaid Health Care Act (HRS § 393) affects most Hawaii workers. Coverage details vary by plan, so always verify your specific benefits before scheduling care.
HMSA uses CVS Caremark as its PBM for most commercial plans. The table below reflects typical CVS Caremark formulary placement for common anxiety medications. Your specific plan (PPO, HMO, HMSA Individual & Family) may differ — always verify through your Summary of Benefits or by calling HMSA at 1-800-776-4672.
| Medication | Drug Class | Typical Tier | Prior Auth? | Notes |
|---|---|---|---|---|
| Sertraline (generic Zoloft) | SSRI | Tier 1 | Usually No | First-line; widely preferred |
| Escitalopram (generic Lexapro) | SSRI | Tier 1 | Usually No | First-line; well-tolerated |
| Fluoxetine (generic Prozac) | SSRI | Tier 1 | Usually No | Also used for panic disorder |
| Paroxetine (generic Paxil) | SSRI | Tier 1–2 | Rarely | Shorter half-life; taper required |
| Venlafaxine ER (generic Effexor XR) | SNRI | Tier 1–2 | Rarely | First-line; broad anxiety coverage |
| Duloxetine (generic Cymbalta) | SNRI | Tier 1–2 | Rarely | Also used for GAD + pain |
| Buspirone (generic BuSpar) | Azapirone | Tier 1 | Usually No | Non-controlled; no dependence risk |
| Hydroxyzine (Vistaril/Atarax) | Antihistamine | Tier 1 | Usually No | Non-controlled; fast-acting PRN option |
| Propranolol (generic Inderal) | Beta-blocker | Tier 1–2 | Rarely | Off-label for situational/performance anxiety |
| Lorazepam (generic Ativan) | Benzodiazepine (Schedule IV) | Tier 2 | Sometimes | Quantity limits; short-term use |
| Clonazepam (generic Klonopin) | Benzodiazepine (Schedule IV) | Tier 2 | Sometimes | Quantity limits; panic disorder |
| Alprazolam (generic Xanax) | Benzodiazepine (Schedule IV) | Tier 2 | Sometimes | Quantity limits; short-term use only |
| Pregabalin (generic Lyrica) | Anticonvulsant (Schedule V) | Tier 2–3 | Sometimes | For GAD; PA may apply depending on plan |
| Brand SSRIs/SNRIs (e.g., Lexapro, Effexor XR) | SSRI/SNRI | Tier 3–4 | Typically Yes | Step therapy: generic trial required first |
Tier 1 = lowest cost share; Tier 4 = highest cost share. Verify your specific plan’s formulary at hmsa.com or by calling 1-866-488-4708 (CVS Caremark PA line for HMSA).
HMSA and CVS Caremark typically require prior authorization (PA) in specific situations. Common PA triggers for anxiety medications include:
To submit a PA request, providers can use the prc.hmsa.com provider portal or call 1-866-488-4708 (CVS Caremark PA line for HMSA plans). Standard PA decisions typically take 2–3 business days; urgent requests may be expedited within 24–72 hours.
Hawaii’s Electronic Prescribing of Controlled Substances (EPCS) law (Haw. Rev. Stat. § 329-38.5) requires electronic prescribing for Schedule II controlled substances only. This has an important practical implication for anxiety treatment:
This differs significantly from states like West Virginia (W. Va. Code § 60A-4-403a), which requires electronic prescribing for all controlled substances including Schedule IV and V. In Hawaii, no anxiety medications currently in common use trigger the EPCS mandate. Patients and providers can proceed with standard prescribing workflows.
Hawaii’s Mental Health Parity and Addiction Equity Law (Haw. Rev. Stat. § 431M-1 et seq.) requires that state-regulated insurance plans cover mental health and substance use disorder (MH/SUD) benefits at parity with medical and surgical benefits. In practice, this typically means:
Important ERISA note: Haw. Rev. Stat. § 431M-1 applies to state-regulated fully insured plans. If your HMSA coverage is through a large self-funded employer plan governed by ERISA, state parity law does not apply directly — but the federal Mental Health Parity and Addiction Equity Act (MHPAEA) provides comparable federal protections. Contact HMSA to determine whether your plan is fully insured or self-funded.
If you believe HMSA has applied parity protections inconsistently, you may file a complaint with the Hawaii Insurance Division at 1-808-586-2790 or insurance.hawaii.gov.
Hawaii has one of the country’s most comprehensive employer health coverage mandates: the Hawaii Prepaid Health Care Act (Haw. Rev. Stat. § 393). Key provisions relevant to anxiety treatment coverage include:
The Prepaid Health Care Act does not mandate specific formulary tiers or PA criteria for anxiety medications — those are governed by your plan’s coverage documents and state/federal parity law. However, it ensures that most Hawaii workers have access to employer-sponsored insurance in the first place.
HMSA’s behavioral health benefits typically extend to a range of anxiety-related diagnoses under applicable parity protections. Conditions that may be covered include:
Treatment types that HMSA may cover (subject to plan benefits and medical necessity) include:
Klarity Health connects patients with 2,000+ licensed providers across Hawaii and the continental U.S. who specialize in anxiety, ADHD, depression, and related conditions. Klarity providers are trained in EPCS-compliant prescribing workflows for Hawaii and can help patients navigate the CVS Caremark formulary, PA requirements, and HMSA’s coverage policies.
Many Klarity patients with HMSA coverage may be able to access anxiety evaluation and medication management with reduced out-of-pocket cost depending on their plan. Coverage and cost share vary — verify your specific benefits before booking.
Check if you may qualify for anxiety treatment at Klarity Health →
HMSA typically covers individual and group psychotherapy for anxiety disorders under its behavioral health benefits, subject to medical necessity and parity protections under Haw. Rev. Stat. § 431M-1. Coverage for specific therapy modalities (CBT, exposure therapy, etc.) depends on your specific plan. Call HMSA at 1-800-776-4672 to confirm your therapy benefits and locate in-network therapists.
Benzodiazepines (alprazolam/Xanax, clonazepam/Klonopin, lorazepam/Ativan) typically appear at CVS Caremark Tier 2 under HMSA plans, with quantity limits. Short-term use is generally covered; long-term coverage may require additional documentation. Importantly, benzodiazepines are Schedule IV — not subject to Hawaii’s EPCS mandate (HRS § 329-38.5 covers Schedule II only) — so no special electronic prescribing requirement applies in Hawaii.
Referral requirements depend on your HMSA plan type. HMSA PPO plans typically do not require a referral to see in-network specialists. HMSA HMO plans may require a referral from your primary care physician. Check your plan’s SBC or call 1-800-776-4672 to confirm whether a referral is needed for behavioral health visits.
No. Hawaii’s EPCS mandate (HRS § 329-38.5) applies to Schedule II controlled substances only. No commonly prescribed anxiety medication is Schedule II. SSRIs, SNRIs, buspirone, hydroxyzine, propranolol, and benzodiazepines (Schedule IV) are all outside Hawaii’s electronic prescribing requirement. Providers may prescribe using any compliant method.
If HMSA denies a claim or PA for an anxiety medication, you typically have the right to a formal appeal. Request a written denial with the specific reason, gather supporting documentation from your provider, and submit an internal appeal. If the internal appeal is denied, you may be entitled to an external review through the Hawaii Insurance Division (1-808-586-2790). Under parity law (§ 431M-1), HMSA must apply the same appeal standards to MH/SUD denials as to medical/surgical denials.
The Hawaii Prepaid Health Care Act (HRS § 393) requires most Hawaii employers to provide health coverage to employees working 20 or more hours per week for four consecutive weeks. If you receive HMSA coverage through your employer, the Act may entitle you to this coverage regardless of your full-time status. The Act does not mandate specific anxiety treatment benefits — those are governed by parity law and your plan’s coverage documents. Contact the Hawaii DLIR at 1-808-586-8777 with employer compliance questions.
Disclaimer: This article is for informational purposes only and does not constitute legal, medical, or financial advice. Coverage descriptions use “may,” “typically,” and “in many cases” because actual benefits vary by plan, employer contract, and individual circumstances. Always verify your specific HMSA plan’s coverage, formulary placement, and prior authorization requirements by reviewing your Evidence of Coverage (EOC) or contacting HMSA member services at 1-800-776-4672 before scheduling care or filling prescriptions. Klarity Health is an independent telehealth provider and is not affiliated with HMSA, Blue Cross Blue Shield Association, or CVS Caremark.
Find the right provider for your needs — select your state to find expert care near you.